Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules
- Published
- 3 Sept 2025
- Units affected
- 8544 bottles
- Agency
- FDA
- Country
- United States
The hazard
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
- Brand / company
- Lannett Company Inc.
- Codes / lots
- Lot #: 25280726A, Exp. Date 03/2027
- Distribution
- Nationwide within the USA
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 3 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.